Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update

Development Program Highlights and Anticipated 2024 Milestones

SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today reported financial results for the quarter ended March 31, 2024 and provided a company update.

Read more at globenewswire.com